Recombinant Human Ataxin-1 (ATXN1), partial

Code CSB-YP002438HU
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP002438HU
Size Pls inquire
Source E.coli
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP002438HU-B
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP002438HU
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP002438HU
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
ATXN1
Uniprot No.
Alternative Names
alternative ataxin1; Ataxin-1; ATX1; ATX1_HUMAN; Atxn1; D6S504E; OTTHUMP00000016065; SCA1; Spinocerebellar ataxia type 1 protein
Species
Homo sapiens (Human)
Protein Length
Partial
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression. Binds RNA in vitro. May be involved in RNA metabolism. In concert with CIC and ATXN1L, involved in brain development.
Gene References into Functions
  1. These convergent evidences support ATXN1 as a promising risk gene for Schizophrenia, and the integrated approach serves as a useful tool for dissecting the genetic basis of schizophrenia. PMID: 29055568
  2. JNK and DUSP18 reciprocally modulate the SUMOylation, which plays a regulatory role in the aggregation of ataxin-1. PMID: 29852174
  3. ATXN1 might contribute to neuronal degeneration leading to ALS. PMID: 29274668
  4. SCA1 mutation carriers performed similarly to controls in the postural tasks with open eyes, whereas in conditions without visual feedback SCA1 carriers had significantly higher stability index than controls at all longitudinal evaluations. Close-to-disease onset carriers (PMID: 28551466
  5. In cervical cancer cells, ATXN1 knockdown induced EMT by directly regulating Snail expression, leading to matrix metalloproteinase activation and the promotion of cell migration and invasion. PMID: 28212558
  6. ATXN1 underexpression is associated with metabolic diseases. PMID: 27918534
  7. data suggest GSK3b and mTOR pathways modulate this ATXN1 function in spinocerebellar ataxia type-1 (SCA1)pathogenesis that could be targeted therapeutically prior to the onset of disease symptoms in SCA1 and other pathologies involving dysregulation of ATXN1 functions. PMID: 27466200
  8. SCA1 phenotypes could be reversed by partial suppression of human mutant ATXN1 mRNA by rAAV.miS1 when delivered after symptom onset in mice. PMID: 27686464
  9. SCA1 relative frequency in Poland shows the highest value compared with the data from other countries worldwide in patient with Spinocerebellar ataxias PMID: 27193757
  10. Studied Ataxin-1 using molecular modeling to investigate the protein-protein interactions contributing to the AXH domain dimer stability. PMID: 26879337
  11. Data indicate that in spinocerebellar ataxia type 1 patients the spinocerebellar ataxia type 1 protein trinucleotide repeat expansion (CAG)n was great than 39, comparing with normal 6-38. PMID: 27577232
  12. This study reports the results of molecular dynamics simulations of AXH monomer of Ataxin-1. PMID: 26522012
  13. Systematic replacement of each lysine residue in the AXH domain revealed that the lysine at 589 (K589) of ATXN1 is essential for its ubiquitylation by UbcH6. PMID: 25641559
  14. Results show that two SNPs in ATXN1 gene have a founder effect of the same repeat carrying allele as in the general Indian population suggesting that that Spinocerebellar ataxia type 1 disease onset is significantly delayed when transmission is maternal. PMID: 25344417
  15. this work provides the structural and molecular basis of the interaction between RBM17 and the phosphorylated form of ATXN1. PMID: 24858692
  16. Partner recognition of the AXH domain of the transcriptional co-regulator ataxin-1 is fine-tuned by a subtle balance between self- and hetero-associations. PMID: 24155902
  17. We measured cerebellar neurochemical alterations in a knock-in mouse model of spinocerebellar ataxia type 1, a hereditary movement disorder, using ultra-high field magnetic resonance spectroscopy (MRS). PMID: 24032423
  18. Data indicate that the alternative ataxin-1 (ATXN1) protein is constitutively co-expressed and interacts with ATXN1. PMID: 23760502
  19. SCA 1 was the most frequent occurring type of SCA identified in the Autosomal dominant hereditary ataxia in Sri Lanka. PMID: 23634774
  20. Results show variation in ATXN1 is implicated in disordered gambling PMID: 22780124
  21. conformational heterogeneity of the AXH domain of ataxin-1 PMID: 23528090
  22. Patients carrying JARID2 deletion manifested with cognitive impairment, gait disturbance and a characteristic facial appearance, whereas patients with deletion of ATXN1 seemed to be characterized by intellectual disability and behavioural abnormalities PMID: 23294540
  23. multiple components of the RAS-MAPK-MSK1 pathway influence ATXN1 levels in Drosophila and human cells PMID: 23719381
  24. This study showed that develop progressive cerebellar degeneration requires expressing ATXN1 with an expanded polyglutamine tract. PMID: 23536093
  25. Both ATXN-1 and ATXN-2 PolyQ intermediate expansions are independently associated with an increased risk for ALS. PMID: 23197749
  26. MED15 and PUM1 proteins with coiled-coil domains are potent enhancers of polyQ-mediated ataxin-1 protein misfolding and proteotoxicity in vitro and in vivo. PMID: 22916034
  27. FOX-2 is involved in splicing of ataxin-2 transcripts and that this splicing event is altered by overexpression of ataxin-1 PMID: 22666429
  28. Data indicate that neuroprotectin D1 (NPD1) synthesis is an early response induced by proteotoxic stress due to abnormally folded ataxin-1. PMID: 22511762
  29. results suggest that expanded ATXN1 may induce unregulated ionic pathways in the nuclear membrane, causing severe damage to the cell PMID: 22330095
  30. This study demonistrated that Disease progressed of autosomal dominant cerebellar ataxia and spastic paraplegia faster in SCA s with polyglutamine expansions in SCA1, 2, and 3. PMID: 22491195
  31. Both ATXN1 and BOAT1 bind to the promoter region of Hey1 and inhibit the transcriptional output of Notch through direct interactions with CBF1, a transcription factor that is crucial for the Notch pathway. PMID: 21475249
  32. This study demonstrates that ataxin-1 occupies the promoter region of E-cadherin in vivo and that ataxin-1 activates the promoter in a CtBP2-mediated transcriptional regulation manner. PMID: 21315774
  33. The ATXN1 gene is related to intelligence in an ADHD background. PMID: 21302343
  34. Phosphorylation of transgenic ataxin-1 at the serine-776 motif is critical for ataxin-1 mediated toxicity. PMID: 20477910
  35. ATXN1 functions as a genetic risk modifier that contributes to AD pathogenesis through a loss-of-function mechanism by regulating beta-secretase cleavage of APP and Abeta levels PMID: 20097758
  36. The neurochemical alterations detected in SCA1[82Q] transgenic mice are primarily due to expansion of the polyglutamine repeat in ataxin-1, rather than the overexpression of the human protein. PMID: 20220018
  37. Together these results indicate that SUMO modification of ataxin-1 promotes the aggregation of ataxin-1 and that oxidative stress and JNK pathway play roles in this process. PMID: 20132795
  38. p62 contributed to the assembly of proteasome-containing degradative compartments in the vicinity of nuclear aggregates containing polyglutamine-expanded Ataxin1Q84 and to the degradation of Ataxin1Q84. PMID: 20018885
  39. in spinocrebellar attaxia, a trinucleotide expansion disease...a possible role of this SCA1 allele with 31 repeats in triplet diseases...a possible role of the SCA1 region in pathological trinucleotide repeat expansions. PMID: 11807410
  40. Spinocerebellar ataxia type 1 (SCA1): phenotype-genotype correlation studies in intermediate alleles PMID: 11973625
  41. Two types of ataxin1 inclusions exist; those undergoing rapid, complete exchange with a nucleoplasmic pool, and those that contain varying levels of slow-exchanging ataxin1. The latter inclusions contain high ubiquitin levels, but low proteasome levels. PMID: 12360291
  42. phylogenetic evidence from deletions in SCA1 PMID: 12411613
  43. p80 coilin protein co-localizes with ataxin-1 aggregates in the nucleoplasm PMID: 12757932
  44. analysis of SCA1 AXH domain structure PMID: 14583607
  45. We demonstrate that abolishing full-length mutant human ataxin-7 transgene expression did not reverse retinopathy progression in SCA7 mice, raising the possibility that some polyQ-induced pathological events might be irreversible. PMID: 14985428
  46. the structural role of the CAU interruptions in the SCA1 transcripts that destabilize the CAG repeat hairpin PMID: 15292212
  47. SCA1 genotypes in a Polish population are significantly different in allele spectra & frequencies from other populations. The dynamic mutation of SCA1 may begin from the expansion of long pure repeat tracts without the prior loss of interruptions. PMID: 15300851
  48. Ataxin-1 localization to inclusions and inclusion dynamics within the nucleus are RNA- and transcription-dependent. PMID: 15615787
  49. polyglutamine-expanded ataxin-1 decreases the activity of the proteasome, implying that a disturbance in the ubiquitin-proteasome pathway is directly involved in the development of spinocerebellar ataxia type 1 PMID: 15750336
  50. A novel phosphorylation site at serine 239 was demonstarted in ataxin-1. PMID: 15878393

Show More

Hide All

Involvement in disease
Spinocerebellar ataxia 1 (SCA1)
Subcellular Location
Cytoplasm. Nucleus.
Protein Families
ATXN1 family
Tissue Specificity
Widely expressed throughout the body.
Database Links

HGNC: 10548

OMIM: 164400

KEGG: hsa:6310

STRING: 9606.ENSP00000244769

UniGene: Hs.434961

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X